Retinal thickness and microvascular alterations observed by optical coherence tomography in antineutrophil cytoplasmic antibody-associated vasculitis: a cross-sectional study

被引:0
|
作者
Li, Zi-Yuan [1 ]
Kang, Min [1 ]
Qian, Xian-Zhe [2 ]
Peng, Rui [1 ]
Hong, Qi [1 ]
Ying, Ping [1 ]
Huang, Hui [1 ]
Wang, Xiao-Yu [1 ]
Zeng, Yan-Mei [1 ]
Hu, Jin-Yu [1 ]
Chen, Xu [3 ]
Wu, Rui [2 ]
Shao, Yi [1 ]
Yu, Shu-Jiao [1 ,2 ]
机构
[1] Nanchang Univ, Jiangxi Med Coll, Affiliated Hosp 1, Dept Ophthalmol, 17 Yongwaizheng St, Nanchang 330006, Peoples R China
[2] Nanchang Univ, Affiliated Hosp 1, Jiangxi Med Coll, Dept Rheumatol, Nanchang, Peoples R China
[3] Maastricht Univ, Ophthalmol Ctr, Maastricht, Netherlands
基金
中国国家自然科学基金;
关键词
Antineutrophil cytoplasmic antibody-associated vasculitis (ANCA-AAV); optical coherence tomography angiography (OCTA); retinal thickness (RT); superficial vascular density (SVD); RHEUMATOLOGY CLASSIFICATION CRITERIA; 2022; AMERICAN-COLLEGE; OCULAR MANIFESTATIONS; FLUORESCEIN ANGIOGRAPHY; DIABETIC-RETINOPATHY; GRANULOMATOSIS; ALLIANCE; DENSITY; OCT;
D O I
10.21037/qims-23-1717
中图分类号
R8 [特种医学]; R445 [影像诊断学];
学科分类号
1002 ; 100207 ; 1009 ;
摘要
Background: As an autoimmune disease, antineutrophil cytoplasmic antibody (ANCA)-associated vasculitis (AAV) often affects multiple organs, including the ocular system. This study aims to investigate differences in retinal thickness (RT) and retinal superficial vascular density (SVD) between patients with AAV and healthy controls (HCs) using optical coherence tomography angiography (OCTA). Currently, these differences are not clear. Methods: A total of 16 AAV individuals (32 eyes) and 16 HCs (32 eyes) were recruited to this crosssectional study conducted in the First Affiliated Hospital of Nanchang University from June 2023 to September 2023. The study protocol conformed with the tenets of the Declaration of Helsinki (as revised in 2013). Each image observed by OCTA was divided into 9 regions using the Early Treatment Diabetic Retinopathy Study (ETDRS) subzones as a guide. Results: In the full layer, the RT of AAV patients was found to be significantly reduced in the inner superior (IS, P<0.001), outer superior (OS, P=0.003), inner temporal (IT, P=0.003), and outer temporal (OT, P<0.001) regions; inner RT was significantly lower in the IS (P=0.006), OS (P<0.001), inner nasal (IN, P=0.005), outer nasal (ON, P<0.001), and center (C, P=0.01) regions than that in HCs. Outer RT of AAV patients showed a reduction in the IS (P<0.001), as well as IT (P=0.008), and OT (P<0.001) regions. No statistically significant differences were seen in the different subregions in other different layers (P>0.05). Only the inner inferior (II) and outer inferior (OI) regions of SVD in AAV patients did not differ significantly from controls. All other regions showed a reduction in SVD. The details are as follows: IS (P<0.001), OS (P<0.001), IT (P=0.005), OT (P<0.001), IN (P<0.001), ON (P<0.001), and C (P=0.003). According to receiver operating characteristic (ROC) curve analysis, the full IS region [area under the curve (AUC): 0.8892, 95% confidence interval (CI): 0.8041-0.9742, P<0.001] had the highest diagnostic value for AAV-induced reduction in RT. The IS (AUC: 0.9121, 95% CI: 0.8322-0.9920, P<0.001) region was also the most sensitive to changes in SVD of AAV individuals. In addition, we found that SVD in the IN region (r=-0.4224, 95% CI: -0.6779 to -0.0757, P=0.02) as well as mean visual acuity (r=-0.3922, 95% CI: -0.6579 to -0.0397, P=0.03) of AAV patients were negatively correlated with disease duration. However, we did not find an association between SVD and RT in this study. Conclusions: The findings from OCTA indicated a reduction in RT and SVD among patients with AAV. OCTA allows for the evaluation of AAV-related ocular lesions and holds promise for monitoring of disease progression through regular evaluations.
引用
收藏
页码:4998 / 5011
页数:14
相关论文
共 50 条
  • [41] Efficacy and Safety of Belimumab and Azathioprine for Maintenance of Remission in Antineutrophil Cytoplasmic Antibody-Associated Vasculitis: A Randomized Controlled Study
    Jayne, David
    Blockmans, Daniel
    Luqmani, Raashid
    Moiseev, Sergey
    Ji, Beulah
    Green, Yulia
    Hall, Leanne
    Roth, David
    Henderson, Robert B.
    Merkel, Peter A.
    ARTHRITIS & RHEUMATOLOGY, 2019, 71 (06) : 952 - 963
  • [42] Systemic immune-inflammation index could estimate the cross-sectional high activity and the poor outcomes in immunosuppressive drug-naive patients with antineutrophil cytoplasmic antibody-associated vasculitis
    Kim, Youhyun
    Choi, Hyeok
    Jung, Seung Min
    Song, Jason Jungsik
    Park, Yong-Beom
    Lee, Sang-Won
    NEPHROLOGY, 2019, 24 (07) : 711 - 717
  • [43] Urinary T Cells Identify Renal Antineutrophil Cytoplasmic Antibody-Associated Vasculitis and Predict Prognosis: A Proof of Concept Study
    Sonnemann, Janis
    Klocke, Jan
    Bieringer, Markus
    Rousselle, Anthony
    Eckardt, Kai-Uwe
    Elitok, Saban
    Popovic, Suncica
    Bachmann, Sebastian
    Kettritz, Ralph
    Salama, Alan D.
    Enghard, Philipp
    Schreiber, Adrian
    KIDNEY INTERNATIONAL REPORTS, 2023, 8 (04): : 871 - 883
  • [44] Pilot Study of Urine Biomarkers for Assessing Kidney Disease in Pediatric-Onset Antineutrophil Cytoplasmic Antibody-Associated Vasculitis
    Mann, Simranpreet
    Vasquez-Rios, Carlos
    Cabral, David
    Morishita, Kimberly
    Brown, Kelly
    JOURNAL OF RHEUMATOLOGY, 2024, 51 : 85 - 85
  • [45] Causal relationship between immune cells and the risk of myeloperoxidase antineutrophil cytoplasmic antibody-associated vasculitis: A Mendelian randomization study
    Cai, Xiaojing
    Li, Junhua
    Wu, Manyi
    Liu, Qingquan
    FASEB JOURNAL, 2024, 38 (14):
  • [46] Predictors of Treatment Resistance and Relapse in Antineutrophil Cytoplasmic Antibody-Associated Vasculitis A Study of 439 Cases in a Single Chinese Center
    Li, Zhi-Ying
    Chang, Dong-Yuan
    Zhao, Ming-Hui
    Chen, Min
    ARTHRITIS & RHEUMATOLOGY, 2014, 66 (07) : 1920 - 1926
  • [47] Efficacy and safety of avacopan in Japanese patients with antineutrophil cytoplasmic antibody-associated vasculitis: A subanalysis of a randomized Phase 3 study
    Harigai, Masayoshi
    Kaname, Shinya
    Tamura, Naoto
    Dobashi, Hiroaki
    Kubono, Shinichi
    Yoshida, Takumitsu
    MODERN RHEUMATOLOGY, 2023, 33 (02) : 338 - 345
  • [48] Antineutrophil cytoplasmic antibody in children with nephrotic syndrome treated with levamisole: a cross-sectional cohort study
    Sinha, Rajiv
    Sarkar, Subhankar
    Banerjee, Sushmita
    Akhtar, Shakil
    Poddar, Sanjukta
    Dasgupta, Deblina
    Saha, Rana
    Sengupta, Jayati
    Mandal, Mita
    Tse, Yincent
    Pahari, Amitava
    PEDIATRIC NEPHROLOGY, 2024, 39 (08) : 2423 - 2427
  • [49] Comparison of severity classification in Japanese patients with antineutrophil cytoplasmic antibody-associated vasculitis in a nationwide, prospective, inception cohort study
    Sada, Ken-ei
    Harigai, Masayoshi
    Amano, Koichi
    Atsumi, Tatsuya
    Fujimoto, Shouichi
    Yuzawa, Yukio
    Takasaki, Yoshinari
    Banno, Shogo
    Sugihara, Takahiko
    Kobayashi, Masaki
    Usui, Joichi
    Yamagata, Kunihiro
    Homma, Sakae
    Dobashi, Hiroaki
    Tsuboi, Naotake
    Ishizu, Akihiro
    Sugiyama, Hitoshi
    Okada, Yasunori
    Arimura, Yoshihiro
    Matsuo, Seiichi
    Makino, Hirofumi
    MODERN RHEUMATOLOGY, 2016, 26 (05) : 730 - 737
  • [50] Measurement of Foveal Retinal Thickness in Myopic Patients Using Different Display Modes on Optical Coherence Tomography: A Retrospective, Cross-Sectional Study
    Dan Jouma A. Maman Lawali
    Guanrong Wu
    Yunxiang Guo
    Zhangjie Lin
    Qiaowei Wu
    Abdou Amza
    Zijing Du
    Yun Ren
    Ying Fang
    Xinran Dong
    Yunyan Hu
    Yongyi Niu
    Hongyang Zhang
    Honghua Yu
    Xiaohong Yang
    Yijun Hu
    Ophthalmology and Therapy, 2023, 12 : 167 - 178